SEC-sourced researchBeta
ACBM
ACRO BIOMEDICAL CO., LTD.
Company comparison ↗
Data passport
- CIK
- 0001622996
- Exchange
- OTC
- Business activity
- — · SIC 7900
- Financial inputs
- 5/6
- Filing date
- Sep 2, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 0.0000 | Feb 11, 2026 |
| December 2025 | 0.0000 | Feb 11, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 0.0000 | -101,146.0000 | -196,302.0000 | 14,098.0000 | — | Feb 11, 2026 |
| December 2024 | 0.0000 | -42,297.0000 | -36,692.0000 | 31,974.0000 | — | Feb 11, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $0 | December 2025 | Feb 11, 2026 | 10-K |
| Previous period revenueRevenues | $0 | December 2024 | Feb 11, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$101.15K | December 2025 | Feb 11, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$196.3K | December 2025 | Feb 11, 2026 | 10-K |
| Total assetsAssets | $14.1K | December 2025 | Feb 11, 2026 | 10-K |
| Total liabilities | — | — | — | — |